185 related articles for article (PubMed ID: 9754544)
1. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK
Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544
[TBL] [Abstract][Full Text] [Related]
2. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD
Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162
[TBL] [Abstract][Full Text] [Related]
3. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
[TBL] [Abstract][Full Text] [Related]
4. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
[TBL] [Abstract][Full Text] [Related]
5. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
[TBL] [Abstract][Full Text] [Related]
6. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
7. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
[TBL] [Abstract][Full Text] [Related]
8. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
9. Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation.
Vogel P; Abplanalp D; Kell W; Ibrahim MS; Downs MB; Pratt WD; Davis KJ
Arch Pathol Lab Med; 1996 Feb; 120(2):164-72. PubMed ID: 8712896
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse.
Charles PC; Trgovcich J; Davis NL; Johnston RE
Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219
[TBL] [Abstract][Full Text] [Related]
11. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
Arya SC; Agarwal N
Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
[No Abstract] [Full Text] [Related]
12. Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains.
Wang E; Bowen RA; Medina G; Powers AM; Kang W; Chandler LM; Shope RE; Weaver SC;
Am J Trop Med Hyg; 2001 Jul; 65(1):64-9. PubMed ID: 11504410
[TBL] [Abstract][Full Text] [Related]
13. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.
Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK
BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies.
Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD
Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice.
Taylor K; Kolokoltsova O; Patterson M; Poussard A; Smith J; Estes DM; Paessler S
Vaccine; 2012 Jun; 30(27):4095-105. PubMed ID: 22525795
[TBL] [Abstract][Full Text] [Related]
17. The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection.
Schäfer A; Brooke CB; Whitmore AC; Johnston RE
J Virol; 2011 Oct; 85(20):10682-90. PubMed ID: 21849461
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
Charles PC; Walters E; Margolis F; Johnston RE
Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
[TBL] [Abstract][Full Text] [Related]
20. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
